Summary

The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April–September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy in the US are creating a major concern for the pharmaceutical industry. Packaging equipment is expected to offer significant growth opportunities within the pharmaceutical industry in Asia-Pacific. Avoidance of counterfeiting and provision of longer shelf life are identified as the key drivers for pharmaceutical packaging companies to witness significant business opportunities within the Asia-Pacific region.

Check Complete Report @ http://www.marketintelreports.com/report/KG6230PR/pharmaceutical-industry-business-outlook-and-procurement-report-h1-2016

Key Findings
•The top three key priorities for H1 2016 (April–September 2016) as identified by respondents include new product development, improving operational efficiency, and expansion in current market
•Developed markets such as the US, the UK, and Japan are identified as important regions for growth over the next six months by pharmaceutical respondents
•New product development and IT infrastructure development will record a significant increase or notable increase in capital expenditure over the next six months
•Overall, 52% of executives operating in Europe assigned high preference for outright purchase of pharmaceutical equipment

Ask for a Sample Brochure, if you want to know more @ http://www.marketintelreports.com/pdfdownload.php?id=KG6230PR

Synopsis
MarketIntelReports Pharmaceutical Industry Business Outlook and Procurement Report H1 2016 examine executives’ opinion on business outlook and procurement activities over April–September 2016. It also highlights key business priorities, supplier price variations, changes in capital expenditure, and the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry. Additionally, it provides information categorized by region and company type.

What else does this report offer?

•Key business priorities: examines the pharmaceutical companies’ important priorities for H1 (April–September) 2016
• Emerging and developed markets: provides information about key emerging and developed markets, which will offer most growth over H1 2016
•Change in M&A activity: analyzes pharmaceutical industry executives’ opinion on changes in merger and acquisition activity globally
•Business concerns: identifies major business concerns that are likely to impact pharmaceutical companies
•Change in capital expenditure: tracks the expected change in capital expenditure both globally and regionally
•Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories
•Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2016 and expectations for 2017
•Equipment and drug categories: highlights the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry from 2016–2020

Reasons To Buy
•Highlights key business priorities thus helping pharmaceutical companies to realign business strategy
•Develop or adjust business expansion plans by using significant growth opportunities offered by key emerging and developed markets
•Make changes in procurement budget allocations through procurement budget projections anticipated by executives for April–September 2016
•Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016
•Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment

Order a copy of Mobile Money: Emerging Trends, Growth Drivers and Future Outlook 2016–2017 report @ http://www.marketintelreports.com/purchase.php?id=KG6230PR

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

About us:
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Contact us:
Mayur S
Sales Manager
2711 Centerville Road, Suite 400,
Wilmington,
Delaware,
19808
United States
www.marketintelreports.com
[email protected]
Telephone: 1-302-684-6088